MERCK KGAA NAM.SP.ADR (MRKC) - Total Liabilities
Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has total liabilities worth €22.87 Billion EUR (≈ $26.73 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MRKC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
MERCK KGAA NAM.SP.ADR - Total Liabilities Trend (2020–2025)
This chart illustrates how MERCK KGAA NAM.SP.ADR's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MRKC asset base.
MERCK KGAA NAM.SP.ADR Competitors by Total Liabilities
The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hengli Petrochemical Co Ltd
SHG:600346
|
China | CN¥205.84 Billion |
|
Hanwha Ocean Co., Ltd
KO:042660
|
Korea | ₩13.06 Trillion |
|
IHH Healthcare Bhd
KLSE:5225
|
Malaysia | RM23.52 Billion |
|
Hyundai Electric & Energy Systems Co Ltd
KO:267260
|
Korea | ₩3.23 Trillion |
|
Fortive Corp
NYSE:FTV
|
USA | $5.55 Billion |
|
Alliant Energy Corp
NASDAQ:LNT
|
USA | $17.39 Billion |
|
RENAU.UNSP.ARD 1/5 EO-20
F:56S0
|
Germany | €3.67 Billion |
|
SDIC Power Holdings Co Ltd
SHG:600886
|
China | CN¥197.75 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down MERCK KGAA NAM.SP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MRKC equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MERCK KGAA NAM.SP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MERCK KGAA NAM.SP.ADR (2020–2025)
The table below shows the annual total liabilities of MERCK KGAA NAM.SP.ADR from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €22.87 Billion ≈ $26.73 Billion |
+5.96% |
| 2024-12-31 | €21.58 Billion ≈ $25.23 Billion |
-0.74% |
| 2023-12-31 | €21.74 Billion ≈ $25.42 Billion |
-3.51% |
| 2022-12-31 | €22.53 Billion ≈ $26.34 Billion |
-5.91% |
| 2021-12-31 | €23.95 Billion ≈ $28.00 Billion |
-3.36% |
| 2020-12-31 | €24.78 Billion ≈ $28.97 Billion |
-- |
About MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more